Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapy
D. Krijgsman, L. Kraaier, M. Verdonschot, S. Schubert, J. Leusen, E. Duiker, R. de Kleine, V. de Meijer, R. de Krijger, J. Zsiros, W. C. Peng, Y. Vercoulen
This paper characterizes the immune landscape of hepatoblastoma, revealing a myeloid-dominated environment with limited T cells and opportunities for macrophage-targeted immunotherapy.
bioRxiv · Jun 28, 2023Cancer Biology